RecruitingNot applicableNCT05954416
FARD (RaDiCo Cohort) (RaDiCo-FARD)
Studying Inherited epidermolysis bullosa
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Principal Investigator
- Christine BODEMERINSERM UMR 1163
- Enrollment
- 900 enrolled
- Eligibility
- All sexes
- Timeline
- 2018 – 2027
Study locations (14)
- Hôpital Avicenne, Bobigny, France
- Hôpital des Enfants - Groupe Hospitalier Pellegrin, Bordeaux, France
- Hôpital Henri-Mondor, Créteil, France
- Hôpital François Mitterrand, Dijon, France
- Hôpital Dupuytren, Limoges, France
- Hôpital de la Timone, Marseille, France
- Hôpital Saint-Eloi, Montpellier, France
- Hôpital l'Archet, Nice, France
- Hôpital Necker-Enfants Malades, Paris, France
- Hôpital Saint-Louis, Paris, France
- Hôpital Robert-Debré, Reims, France
- Hôpital Charles Nicolle, Rouen, France
- Hôpital Larrey, Toulouse, France
- Hôpital Trousseau, Tours, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05954416 on ClinicalTrials.govOther trials for Inherited epidermolysis bullosa
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE3NCT05838092Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)RHEACELL GmbH & Co. KG
- ACTIVE NOT RECRUITINGPHASE3NCT05464381Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)RHEACELL GmbH & Co. KG
- ACTIVE NOT RECRUITINGNANCT05248503Impact of Complex Care Training of Hereditary Epidermolysis Bullosa on Caregiver Burden (FIREB)Assistance Publique - Hôpitaux de Paris